Repeat Surgery
Related entities
Findings (27)
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46
None
adverseVaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.
Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46